Corcept Therapeutics Incorporated

CORT · Healthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…

Corcept Therapeutics Incorporated (CORT), in the Healthcare sector, has 50 disclosed filings on Paydirt over the trailing twelve months from 11 corporate insiders: 1 purchase and 49 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 2 and filed Sep 4. The most active filer was William Guyer with 24 filings.

Add to watchlist

Filings, ttm

1 buy · 49 sells · 1 late

Traders, ttm

11 insiders

Volume, ttmiDollar value disclosed in the window

$100.0M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 2

Filed Sep 3

ADViAverage daily dollar volume

$130.9M

market data

Share price · 12M

$112 (+39.5%)

Adjusted for splits and dividends.

Volume by month

Buys $3.3M Sells $173.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

William Guyer Chief Development Officer 24 filings SM

Sean Maduck See Remarks 21 filings JL

Joseph Douglas Lyon See Remarks 14 filings JB

Joseph K Belanoff Chief Executive Officer 13 filings DJ

Daniel N Swisher JR Director 12 filings GR

Gary Charles Robb Chief Business Officer 7 filings AM

Atabak Mokari Chief Financial Officer 4 filings DM

David L Mahoney Director 3 filings

Recent filings

Sean MaduckSALE See Remarks $2.9M
25,000 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:16 PM ET Roberto Wandenkolk VieiraSALE President, Oncology $6.5M
58,333 sh across 7 lots
Exec Sep 2
Filed Sep 3 · 9:02 PM ET Sean MaduckSALE See Remarks $3.9M
30,955 sh across 2 lots
Exec Aug 25
Filed Aug 27 · 4:30 PM ET David L MahoneySALE Director $12.2M
103,206 sh across 3 lots
Exec Aug 18
Filed Aug 20 · 4:30 PM ET Sean MaduckSALE See Remarks $419K
3,664 sh × $114.49
Exec Aug 14
Filed Aug 18 · 4:30 PM ET James N WilsonSALE Director $1.1M
10,000 sh across 3 lots
Exec Aug 14
Filed Aug 18 · 4:30 PM ET Gary Charles RobbSALE Chief Business Officer $1.2M
10,000 sh × $116.26
Exec Aug 17
Filed Aug 18 · 4:30 PM ET Sean MaduckSALE See Remarks $118K
1,031 sh × $114.52
Exec Aug 10
Filed Aug 12 · 4:27 PM ET William GuyerSALE Chief Development Officer $1.8M
16,300 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 4:26 PM ET William GuyerSALE Chief Development Officer $419K
3,700 sh × $113.12
Exec Aug 4
Filed Aug 6 · 6:44 PM ET Sean MaduckSALE See Remarks $2.3M
20,305 sh × $114.70
Exec Aug 3
Filed Aug 5 · 5:51 PM ET Joseph Douglas LyonSALE See Remarks $176K
1,540 sh × $114.16
Exec Aug 3
Filed Aug 5 · 5:48 PM ET Atabak MokariSALE Chief Financial Officer $9.1M
79,000 sh across 11 lots
Exec Jul 30
Filed Aug 3 · 4:30 PM ET James N WilsonSALE Director $789K
8,921 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:38 PM ET Atabak MokariSALE Chief Financial Officer $3.5M
39,899 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:31 PM ET William GuyerSALE Chief Development Officer $1.8M
19,048 sh × $93.11
Exec Jul 7
Filed Jul 8 · 7:54 PM ET Sean MaduckSALE See Remarks $2.2M
25,000 sh across 3 lots
Exec Jul 1
Filed Jul 6 · 4:44 PM ET David L MahoneySALE Director $1.7M
20,000 sh × $84.53
Exec Jun 17
Filed Jun 18 · 5:30 PM ET James N WilsonSALE Director $832K
10,000 sh across 2 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET Atabak MokariSALE Chief Financial Officer $3.2M
39,998 sh across 3 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET William GuyerSALE Chief Development Officer $1.4M
20,000 sh × $70.60
Exec Jun 2
Filed Jun 4 · 5:30 PM ET Atabak MokariSALE Chief Financial Officer $2.8M
40,000 sh × $70.00
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Sean MaduckSALE See Remarks $1.8M
25,000 sh across 2 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Joseph K BelanoffSALE Chief Executive Officer $895K
12,837 sh × $69.74
Exec Jun 1
Filed Jun 2 · 5:30 PM ET Sean MaduckSALE See Remarks $4.9M
75,000 sh across 2 lots
Exec May 27
Filed May 29 · 5:30 PM ET